成人型皮肌炎与糖尿病患病率增加相关且不依赖糖皮质激素使用
该回顾性队列研究纳入434例成人型皮肌炎患者,按1:2倾向性评分匹配对照,发现皮肌炎组糖尿病患病率为23.6%,显著高于对照组的10.5%(p<0.001),且超过半数糖尿病诊断发生于糖皮质激素启用之前;校正匹配因素后,成人型皮肌炎仍与糖尿病风险独立相关(OR 1.06;p=0.008)。
要点
- 成人型皮肌炎患者糖尿病患病率显著高于匹配对照人群。
- 多数糖尿病诊断发生在糖皮质激素启用之前,提示风险不完全由激素解释。
- 高BMI、高血压和血脂异常与皮肌炎患者糖尿病风险显著相关。
核心结论
- 成人型皮肌炎与糖尿病患病率显著升高相关,且该关联独立于糖皮质激素暴露。
研究设计与样本
- 采用美国糖尿病协会标准经回顾性病历审查识别糖尿病,并评估皮肌炎诊断、糖尿病发病与糖皮质激素启用之间的时间关系。
- 以年龄、性别、体重指数、种族、吸烟状态、高血压和血脂异常为匹配变量,按1:2比例进行倾向性评分匹配设置同期非皮肌炎对照队列。
- 采用逻辑回归识别糖尿病危险因素。
主要发现
- 成人型皮肌炎患者糖尿病患病率为23.6%,对照组为10.5%(p < 0.001)。
- 超过半数的糖尿病诊断发生于糖皮质激素启用之前。
- 在成人型皮肌炎患者中,较高的体重指数、高血压和血脂异常与糖尿病显著相关,而肌炎特异性抗体和肌炎相关抗体与糖尿病无显著关联。
- 与匹配对照相比,成人型皮肌炎独立与糖尿病风险增加相关(比值比1.06;p = 0.008)。
关键数值与推荐
- 糖尿病依据美国糖尿病协会标准诊断。
- 倾向性评分匹配比例为1:2,匹配变量包括年龄、性别、体重指数、种族、吸烟状态、高血压和血脂异常。
临床怎么用
- 对成人型皮肌炎患者应尽早开展心血管代谢筛查,包括糖尿病评估。
- 筛查不应仅因患者未使用糖皮质激素而放松,因多数糖尿病诊断发生在激素启用前。
- 对合并高体重指数、高血压或血脂异常的成人型皮肌炎患者应加强糖尿病监测。
局限性
- 研究为单中心回顾性病历审查设计。
- 摘要未报告研究人群的地域代表性及糖尿病筛查频率差异等潜在偏倚信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Much of the evidence for a high prevalence of diabetes mellitus in dermatomyositis comes from studies of juvenile-onset dermatomyositis patients. Also, glucocorticoid therapy may confound diabetes risk. Our study evaluated the prevalence of diabetes in adult-onset dermatomyositis, independent of glucocorticoid exposure, identified associated risk factors, and compared diabetes prevalence with that of a matched control population. METHODS: Our institutional database was queried to identify patients with adult-onset dermatomyositis using ICD-9 and ICD-10 codes over a 15-year study period (January 1, 2007 - December 31, 2021). Retrospective chart review identified diabetes using American Diabetes Association criteria and assessed the temporal relationship among adult-onset dermatomyositis diagnosis, diabetes onset, and glucocorticoid initiation. A contemporaneous non-dermatomyositis control cohort was identified. Propensity score matching at a 1:2 ratio was performed based on age, sex, body mass index, race, smoking status, hypertension, and dyslipidemia. Diabetes risk factors were identified using logistic regression. RESULTS: The adult-onset dermatomyositis cohort included 434 patients with a median age of 64 years. Diabetes was present in 23.6% of adult-onset dermatomyositis patients compared with 10.5% of controls (p < 0.001). Over half of diabetes diagnoses occurred before glucocorticoid initiation. Among patients with adult-onset dermatomyositis, higher body mass index, hypertension, and dyslipidemia were significantly associated with diabetes, whereas myositis-specific and associated antibodies were not. Adult-onset dermatomyositis was independently associated with increased odds of diabetes compared with matched controls (odds ratio 1.06; p = 0.008). CONCLUSION: Adult-onset dermatomyositis is associated with a significantly higher prevalence of diabetes independent of glucocorticoid exposure, supporting the need for early cardiometabolic screening in this population. FUNDING: None.
引用
- Ejaz K, Zhang C, Chatterjee S, et al. Adult-onset dermatomyositis is associated with an increased prevalence of diabetes mellitus independent of glucocorticoid use. Semin Arthritis Rheum. 2026. PMID: 42364376. doi:10.1016/j.semarthrit.2026.153028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。